BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
12/2/16 Boehringer Ingelheim Jardiance for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
12/2/16 Novo Nordisk (NVO) Xultophy for Diabetes Mellitus, Type II Subscribers Only Subscribers Only Subscribers Only
12/2/16 NeuroDerm (NDRM) ND0701 for Parkinson's Disease (PD) Subscribers Only Subscribers Only Subscribers Only
12/2/16 GlaxoSmithKline (GSK) FF/UMEC/VI for Chronic Obstructive Pulmonary Disease (COPD) Subscribers Only Subscribers Only Subscribers Only
12/2/16 Amgen (AMGN) Biosimilar Bevacizumab (Amgen) for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
12/03/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
12/03/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
12/03/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
12/03/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
12/03/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results